Search results
Israel’s Once-Dominant Drugmaker Is Revived by Innovation
The Wall Street Journal via Yahoo Finance· 1 day agoLast year, Merck agreed to pay $10.8 billion for a drug in the same category, yet right now...
Cinven to explore $3 billion sale of software maker Jaggaer, sources say
Reuters via Yahoo News· 2 days agoPrivate equity firm Cinven is preparing to explore a sale of Jaggaer that it hopes will value the maker of supply chain software at about $3 billion, including ...
mAbxience Appoints Jurgen Van Broeck as New CEO
WRBL Columbus· 6 days agoof Jurgen Van Broeck as Chief Executive Officer. Jurgen, who has served as Global Commercial Director since June 2023, brings a great deal of experience ...
Iovance (IOVA) Q1 Earnings Surpass, Sales Lag Estimates
Zacks via Yahoo Finance· 5 days agoIovance (IOVA) reports mixed first-quarter results. Shares gain on encouraging initial demand for...
Why Lilly And Novo Nordisk Will Keep Dominating The Market For Blockbuster GLP-1 Drugs
Forbes· 16 hours agoThe mass interest in GLP-1 drugs has led to a business boom for the two dominant pharmaceutical...
7 Weight Loss Drug Stocks Poised for Explosive Growth by 2025
InvestorPlace via Yahoo Finance· 6 days agoInvestors are well aware of the explosive growth potential in weight loss drug stocks. That growth...
Veeva and H&E Equipment Services have been highlighted as Zacks Bull and Bear of the Day
Zacks via Yahoo Finance· 2 days ago“We believe the easing in the progression of construction spending is in part the result of a...
Astellas Showcases Scientific Advancements Across its Oncology Portfolio at 2024 ASCO Annual Meeting
WPRI Providence· 2 days agoAstellas Pharma Inc. (TSE: 4503, President and CEO: Naoki Okamura, "Astellas") will share new research from across its innovative portfolio of approved ...